Pfizer has recalled specific bottles of LIPITOR (40 mg only) due to a small number of reports of an uncharacteristic odor related to the bottles in which LIPITOR is packaged. The odor is not likely to cause adverse health consequences in patients taking LIPITOR. But patients are advised that if they take LIPITOR 40 mg and experience an uncharacteristic odor associated with their medication, to please return the tablets to your pharmacist.
See further details here.
About the Author
Tom D'Amore is the founder of D'Amore Law Group and a trial attorney with over 30 years of experience representing injured people and their families across the West Coast, securing more than $325 million in recoveries. He handles cases involving
car accidents,
trucking accidents,
construction injuries,
medical malpractice, and
sexual abuse. Licensed in Oregon, Washington, and California, Tom is the only NBTA board-certified truck accident attorney in Oregon. He is a national Board of Governors member, past Executive Committee member, and past Budget and Audit Chair of the American Association for Justice, as well as past President of the Oregon Trial Lawyers Association and an Eagle member of the Washington State Association for Justice.
